NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 45 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 25 | -93.5% | 0.00% | – |
| Q3 2021 | $1,000 | -99.6% | 385 | -99.2% | 0.00% | – |
| Q2 2021 | $231,000 | -39.1% | 48,311 | -5.7% | 0.00% | – |
| Q1 2021 | $379,000 | +11.5% | 51,222 | +5.4% | 0.00% | – |
| Q4 2020 | $340,000 | +335.9% | 48,581 | +370.4% | 0.00% | – |
| Q3 2020 | $78,000 | -31.0% | 10,328 | -19.9% | 0.00% | – |
| Q2 2020 | $113,000 | +14.1% | 12,899 | -6.2% | 0.00% | – |
| Q4 2019 | $99,000 | – | 13,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $494,000 | 0.50% |
| CARNEGIE MELLON UNIVERSITY | 939,412 | $986,000 | 0.50% |
| CM Management, LLC | 370,000 | $389,000 | 0.41% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $1,050,000 | 0.40% |
| Sio Capital Management, LLC | 906,445 | $952,000 | 0.36% |
| AIGH Capital Management LLC | 1,027,585 | $1,079,000 | 0.28% |
| Greenlight Capital | 2,727,027 | $2,863,000 | 0.22% |
| Worth Venture Partners, LLC | 256,553 | $249,000 | 0.15% |
| PERKINS CAPITAL MANAGEMENT INC | 81,500 | $86,000 | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $327,000 | 0.01% |